公司资料
Ligand Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- LGND
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
302.74 USD (-3.08%)
收盘价
最后更新: 2026年10月1日
4.66B USD
市值
股价为何变动
截至 2026年10月1日，LGND 下跌 3.08%，收于 $302.74。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Ligand Pharmaceuticals is a royalty and technology-enabled biopharma company that monetizes its platform through partnered programs, royalties, and biopharma investments.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Ligand sits in specialty biopharma and royalty-driven healthcare.
商业模式特征
The business relies on royalties, milestones, and platform economics rather than a single large commercial franchise.
生物医药行业定位
Ligand is a unique biotech finance-and-royalty hybrid whose stock often tracks deal flow and royalty visibility.
未来催化剂
- Ligand's catalysts are royalty income, portfolio monetization, and capital-allocation updates that show how the company keeps converting assets into cash flow. The story is more about financial engineering than a single drug event.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。